Yale UniversityNew Haven, CT
Disclosures:
2063 - Outcomes of Stereotactic Body Radiotherapy (SBRT) in Patients with Oligometastatic or Oligoprogressive Lung Metastases from Renal Cell Cancer (RCC)
Sunday, September 29, 20242:45 PM – 4:15 PM ET